Cubist Systematic Strategies, LLC Akero Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.76 - $31.18 $33,442 - $58,711	1,883 Added 35.96%	7,119 $179,000
Q4 2023 Feb 14, 2024	SELL	$11.38 - $50.33 $216,333 - $956,773	-19,010 Reduced 78.4%	5,236 $122,000
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $998,692 - $1.27 Million	24,246 New	24,246 $1.23 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $3.57 Million - $4.81 Million	-95,706 Reduced 82.87%	19,778 $756,000
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $56,547 - $92,666	-1,691 Reduced 1.44%	115,484 $6.33 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $983,859 - $3.3 Million	96,932 Added 478.84%	117,175 $3.99 Million
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $98,216 - $184,277	12,277 Added 154.12%	20,243 $191,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $80,660 - $138,434	6,219 Added 355.98%	7,966 $113,000
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $24,062 - $31,776	-1,211 Reduced 40.94%	1,747 $37,000
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $124,115 - $169,436	-6,655 Reduced 69.23%	2,958 $66,000
Q2 2021 Aug 16, 2021	BUY	$24.81 - $32.35 $238,498 - $310,980	9,613 New	9,613 $238,000
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $164,169 - $233,483	-6,829 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $121,304 - $144,338	4,829 Added 241.45%	6,829 $176,000
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $39,411 - $51,097	1,280 Added 177.78%	2,000 $62,000
Q2 2020 Aug 14, 2020	SELL	$19.25 - $26.76 $18,999 - $26,412	-987 Reduced 57.82%	720 $18,000
Q1 2020 May 15, 2020	BUY	$12.8 - $27.05 $8,422 - $17,798	658 Added 62.73%	1,707 $36,000
Q4 2019 Feb 14, 2020	SELL	$17.37 - $27.27 $26,992 - $42,377	-1,554 Reduced 59.7%	1,049 $23,000
Q3 2019 Nov 14, 2019	SELL	$16.89 - $29.88 $33,053 - $58,475	-1,957 Reduced 42.92%	2,603 $59,000
Q2 2019 Aug 14, 2019	BUY	$18.08 - $19.83 $82,444 - $90,424	4,560 New	4,560 $87,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

Wellington Management Group LLP Boston, MA

7.9M
Shares

$232 Million
0.04% of portfolio
Janus Henderson Group PLC London, X0

7.08M
Shares

$208 Million
0.11% of portfolio
Rtw Investments, LP New York, NY

5.92M
Shares

$174 Million
2.71% of portfolio
Black Rock Inc. New York, NY

5.59M
Shares

$164 Million
0.0% of portfolio
General Atlantic LLC New York, NY

5.23M
Shares

$154 Million
4.29% of portfolio

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.36B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account